openPR Logo
Press release

Bacterial Vaginosis Drugs Market to See Massive Growth by 2029

02-11-2023 06:26 AM CET | Health & Medicine

Press release from: Orion Market Research

Bacterial Vaginosis Drugs Market to See Massive Growth by 2029

Bacterial vaginosis (BV) drugs market is anticipated to grow at a significant CAGR during the forecast period. The rising incidence of bacterial vaginosis among women across the globe coupled with the surging demand for OTC products is augmenting the growth of the market. It is a vaginal disorder that produces vaginal discharge on account of an overgrowth of certain kinds of bacteria in the vagina. BV is a global concern due to the increased risk of the acquisition of sexually transmitted infections. BV can occur in any age group, however, globally it is more prevalent in females of reproductive age. 

According to the American Sexual Health Association 2019, BV is a common gynecologic infection, which affects nearly 29% of women in the US. At least 15% of the sexually active population are suffering from BV; due to this BV is three-four times more common than urinary tract infections (UTI). Hence, the rising incidence of BV is leading to an upsurge in R&D for its treatment by private manufacturers and research organizations. However, several clinical trials are undergoing to enlarge the potential future of bacterial vaginosis drugs. 

Key players of the market include Bayer AG, Pfizer Inc., and Sanofi S.A., among others. The market players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in August 2020, Daré Bioscience, Inc., one of the prominent leaders in women's health innovation, announced the publication of a proof of concept study of DARE-BV1 in Clinical and Experimental Obstetrics & Gynecology, an international journal focused on the publication of high-quality scientific research related to obstetrics and gynaecology and women's health. DARE-BV1 is a novel thermosetting bioadhesive hydrogel containing clindamycin phosphate 2% that is being evaluated as a one-time vaginally administered treatment for bacterial vaginosis (BV).

To Request a Sample of our Report on Bacterial Vaginosis Drugs Market:  https://www.omrglobal.com/request-sample/bacterial-vaginosis-drugs-market

Market Coverage

The market number available for - 2021-2029
Base year- 2021
Forecast period- 2023-2029
Segment Covered
Regions Covered- Globally
Competitive Landscape: Bayer AG, Pfizer Inc., and Sanofi S.A., among others.

Bacterial Vaginosis Drugs Market by Segmentation

By Type 

Rx 
OTC

By Application 

Hospital
Pharmacy
Others

A full Report of Bacterial Vaginosis Drugs Market is Available at:  https://www.omrglobal.com/industry-reports/bacterial-vaginosis-drugs-market

Bacterial Vaginosis Drugs Market by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://www.asiatimeskorea.com/news/%eb%b0%98%eb%a0%a4%eb%8f%99%eb%ac%bc-%ec%88%98%ec%88%a0-%ed%9b%84-%ed%86%b5%ec%a6%9d-%ea%b4%80%eb%a6%ac-%ec%b9%98%eb%a3%8c%ec%a0%9c-%ec%8b%9c%ec%9e%a5%ec%9d%80-%ec%98%88%ec%b8%a1-%ea%b8%b0%ea%b0%8420/326216/
https://monblogapple.com/2023/02/10/le-marche-des-medicaments-a-base-derythropoietine-devrait-assister-a-une-acceleration-de-la-croissance-dici-2029/
https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%b1%d8%ac%d8%ad-%d8%a3%d9%86-%d9%8a%d8%b4%d9%87%d8%af-%d8%b3%d9%88%d9%82-%d8%a5%d8%af%d8%a7%d8%b1%d8%a9-%d8%a7%d9%84%d9%85%d8%b1%d8%a7%d9%81%d9%82-%d9%86%d9%85%d9%88/
https://www.diario-ya.com/regionales/%e5%88%b0-2023-%e5%b9%b4%e8%87%b3-2029-%e5%b9%b4%ef%bc%8c%e4%bf%9d%e9%9a%aa%e5%88%86%e6%9e%90%e5%b8%82%e5%a0%b4%e5%b0%87%e5%87%ba%e7%8f%be%e5%bc%b7%e5%8b%81%e5%a2%9e%e9%95%b7/388299/
https://citytoday-hildesheim.de/index.php/2023/02/10/der-markt-fur-fettkartuschen-soll-bis-2023-2029-ein-starkes-wachstum-verzeichnen/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Vaginosis Drugs Market to See Massive Growth by 2029 here

News-ID: 2925783 • Views:

More Releases from Orion Market Research

Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033. Digital Innovation in Insurance Market Overview The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033. Cigarette Rolling Paper Market Overview The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers
Back Glue Market: Emerging Trends and Growth Forecast to 2033
Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033. Back Glue Market Overview The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033. Autopilot Systems Market Overview The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These

All 5 Releases


More Releases for Bacterial

Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market? The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training. The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as